文章核心观点 - 文章基于作者35年金融行业经验，提出在当前市场波动和超买环境下，拥有强劲资产负债表、可持续派息比率且定期支付并增加股息的大型高股息公司是增长型和收益型投资者的最佳选择[3][4][6] - 股息投资不仅是一种收入策略，更是通过持续向股东返还资本、同时保持财务稳定并提供高总回报潜力的公司来积累财富的全面框架[5] - 自1926年以来，股息贡献了标普500指数总回报的约32%，过去50年股息股票年化回报率达9.18%，是非派息公司回报率3.95%的两倍多[7] 推荐公司分析 ConocoPhillips (NYSE: COP) - 是一家勘探和生产公司，去年以225亿美元收购了Marathon Oil，为其投资组合增加了鹰福特和二叠纪页岩等高质量资产[8] - 股息收益率为3.57%，业务覆盖阿拉斯加、美国本土48州、加拿大、欧洲、中东、北非和亚太地区等多个国际区域[8][9] - 杰富瑞给予买入评级，目标价120美元[10] Ford Motor Co. (NYSE: F) - 这家美国汽车公司由亨利·福特等人于1903年创立，向股东支付丰厚的4.83%股息[11] - 在全球范围内开发、交付和服务一系列福特卡车、商用车、运动型多用途车和林肯豪华车，业务通过福特Blue、福特Model e、福特Pro、福特Next和福特信贷五个部门运营[11][19] - 巴克莱银行给予增持评级，目标价14美元[14] Johnson & Johnson (NYSE: JNJ) - 是一家跨国美国公司，专注于制药、生物技术和医疗器械，远期市盈率为14.5倍，股息收益率为2.60%[15] - 业务分为创新药和医疗器械两个部门，创新药部门专注于免疫学、传染病、神经科学、肿瘤学等领域[16][20] - 高盛目标价为213美元[17] Prudential Financial Inc. (NYSE: PRU) - 在美国和国际上提供保险、投资管理和其他金融产品及服务，股息收益率高达5.04%[18] - 业务通过PGIM、退休策略、团体保险、个人寿险和国际业务五个部门运营[21][22][23] - 杰富瑞给予买入评级，目标价134美元[23] Verizon Communications Inc. (NYSE: VZ) - 是一家美国跨国电信公司，远期市盈率（基于2026年预期收益）为9.13倍，股息收益率为6.63%，2025年迄今仅上涨2%[24] - 过去12个月利息覆盖率为4.6倍至5.0倍，为股息支付提供了充足缓冲，业务分为消费者和企业两个部门[25][26][28] - TD Cowen给予买入评级，目标价51美元[30]

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs; (2) Perrigo needed to make substantial capital and operational expenditures above the Company's outwardly stated cost estimates to remediate the infant formula business; (3) there were significant manu ...

Accessibility StatementSkip Navigation NEW YORK, Dec. 1, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). Shareholders who purchased shares of TLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of TLX during ...

Submission of NDA in South Korea by Lotus Pharmaceutical results in the second ex-U.S. regulatory submission for VIZZSAN DIEGO and TAIPEI, Taiwan, Dec. 01, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Lotus Pharmaceutical Co., Ltd. (“Lotus”, TWSW Stock Code: 1795) today announced that Lotus has submitted a New Drug Application (NDA) to the Ministry of Food and Drug Safety (MFDS) for the review and approval of VIZZTM, for the treatment of presbyopia in adults in South Korea. This repre ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive In the pivotal Phase 3 Vivacity-MG3 and Phase 2/3 Vibrance-MG studies over 24 weeks, nipocalimab demonstrated rapid and substantial reduction in immunoglobulin G levels, one of the root causes of gMG gMG patients taking nipocalimab demonstrated up to 20 months of sustained disease control and symptom relief in the Vivacity-MG3 study and ongoing open-lab ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that the first participant has been enrolled in the BLOOM Phase 2 clinical study evaluating MRM-3379 in Fragile X syndrome (FXS). Caused by a mutation of the FMR1 gene, FXS is the most common inherited form of intellectual disability and autism spectrum disorder and affects an estimated 50,000 males in the U.S. and E.U. There are currently no approved therapies for t. ...

礼来公司降价 - 礼来公司通过其LillyDirect直接面向消费者平台降低减肥药Zepbound单剂量小瓶的现金成本[1] - 降价后患者每月现金购买价格区间为299美元至449美元 较之前的349美元至499美元价格区间有所下降[2] - 此次降价行动发生在特朗普总统与礼来及其竞争对手诺和诺德签署协议以使其重磅减肥药更易获得和负担得起数周后[2] 电影行业表现 - 今年感恩节周末票房收入约为2.94亿美元 有望成为历史上最好的票房表现之一[4] - 迪士尼电影《疯狂动物城2》以约1.56亿美元的预估收入领先票房[4] - IMAX在为期五天的假日周末期间全球票房收入达4080万美元 创下历史新高 较去年创下的纪录增长70%[5] 空客公司问题 - 欧洲上市的空客股价因报道称其数十架A320系列飞机面临工业质量问题而下跌[7] - 据报道 机身面板缺陷影响了飞机 导致部分交付延迟 但无迹象表明该问题影响现役飞机[8] - 公司就导致约6000架A320系列飞机在假日周末停飞的软件故障发表声明道歉[8] 殡葬行业挑战 - 提供个性化纪念产品（如墓碑）的家族企业面临双重挑战 需适应火化率上升的趋势[9] - 近期特朗普的关税增加对其利润构成额外压力 尽管有关税 企业仍因美国劳动力成本较高而继续进口花岗岩[10] - 某些类型的石材仅在国外生产 正如Rome Monument的John Dioguardi所言“上帝将不同的美味赐予了世界不同地区”[10]

公司行动 - 礼来公司宣布降低其广受欢迎的肥胖症药物Zepbound单剂量小瓶的价格[1] - 此次降价旨在使美国患者更能负担得起该治疗[1] 行业背景 - 市场对减肥疗法的需求持续旺盛[1]

公司业绩与预期 - 公司预计于1月30日公布2025年第四季度业绩，华尔街分析师预期每股收益为3.36美元，较上年同期的2.16美元有所增长 [1] - 2025年第四季度预期营收为163.9亿美元，高于上年同期的151亿美元 [1] - 2025年第三季度营收为157.8亿美元，超过市场预期的155.9亿美元，调整后每股收益为1.86美元，高于市场预期的1.79美元 [5] - 公司将2025年全年调整后每股收益指引上调至10.61美元至10.65美元，此前指引区间为10.38美元至10.58美元，市场预期为10.53美元 [6] 历史股价与投资回报 - 公司股票10年前股价约为60.29美元，若投资1万美元可购买约166股，当前股价为232.32美元，仅股价升值部分投资价值可达38,509美元 [2] - 过去10年间公司每股累计派发股息约48.95美元，投资1万美元可获得约8,119美元股息收入 [3] - 投资1万美元10年后的总价值为46,628美元，总回报率为366.28%，同期标普500指数的总回报率为282.60% [3] 分析师观点与股息表现 - 基于28位分析师评级，公司共识评级为“增持”，目标股价为232.65美元，较当前股价潜在上涨空间约0.1% [5] - 公司当前股息收益率为3.02%，并且已连续12年提高股息 [6]

BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a Company overview and clinical progress update at NobleCon 21 – Noble Capital Markets 21st Emerging Growth Equity Conference on Wednesday, December 3, 2025 at 10:00 am Eastern time. The conference is being held at the Executive Education Complex of Florida Atlantic University in Boca Raton, Florida. Interested investors and guests o ...